Collaboration hub For Testing Laboratories

Connect Test Evidence to Biological-Evaluation Documentation

A clear evidence-to-documentation handoff can help sponsors understand how protocols, results, device context, and remaining uncertainty fit into the wider ISO 10993 evaluation—without compromising laboratory or scientific independence.

Discuss an Evidence-to-Documentation Collaboration See Example Handoffs

The Evidence Interface

A laboratory report is important evidence—not the entire biological evaluation.

Testing laboratories own method suitability, study conduct, quality controls, deviations, raw-data governance, and the laboratory report. Sponsors still need to connect that evidence to device configuration, materials, contact, duration, chemistry, literature, prior evidence, uncertainty, and lifecycle change.

MedDev Advisory can support that sponsor-facing planning and documentation layer while keeping test execution, laboratory conclusions, and independent biological-evaluation judgment visibly separate.

The laboratory retains testing and report ownership

MedDev Advisory owns only the agreed documentation layer

No incentive may influence test selection or conclusions

Complementary Work

Where the Documentation Layer Can Help

Pre-Test Evidence Review

Identify the biological questions, available evidence, uncertainties, and device-specific inputs before a sponsor treats a standard table as an automatic test list.

BEP Integration

Explain why a test, alternative evidence route, or no-new-testing rationale fits the overall evaluation and stated device configuration.

Evidence Traceability

Map protocol/report identifiers, samples, extraction conditions, deviations, results, chemistry, and remaining uncertainty into the client file.

BER Documentation

Place laboratory evidence within the full biological-evaluation narrative rather than repeating the report or claiming that one result closes every risk question.

Gap & Deviation Framing

Identify what a deviation, unexpected result, missing device context, or nonrepresentative sample means for the wider documentation package.

Lifecycle Updates

Assess how later material, supplier, processing, sterilisation, packaging, or use changes affect the evidence chain and need for review.

Representative Handoffs

Three Ways the Interface Can Work

These are illustrative operating patterns, not partner claims or guarantees of a regulatory result.

Independent Sponsor Referral

The laboratory identifies that a sponsor needs wider biological-evaluation support. The sponsor contacts MedDev Advisory directly; each party scopes, contracts, invoices, and owns its work independently.

Defined Documentation Workstream

A written scope covers evidence inventory, BEP/BER input, or gap review. The laboratory provides authorised final protocols and reports; MedDev Advisory documents how they fit the sponsor's broader evidence package.

Coordinated Sponsor Discussion

The sponsor, laboratory, and MedDev Advisory hold a defined technical exchange. Questions, decisions, document owners, and follow-up actions are recorded without merging responsibilities.

Scientific & Commercial Safeguards

Independence Must Be Visible in the Model

Laboratory responsibility

Method, protocol, sample receipt, study conduct, quality controls, deviations, raw data, and final laboratory report
Accurate statements about accreditation, validated capability, and study limitations
Commercial terms for laboratory services, independent of MedDev Advisory conclusions

MedDev Advisory responsibility

Only the agreed biological-evaluation planning, evidence-integration, or documentation workstream
Transparent assumptions, gaps, uncertainties, and qualification boundaries
No laboratory selection guarantee, test-volume incentive, testing commission, or predetermined scientific conclusion

Referral compensation safeguard: if compensation were ever used, it would be disclosed to the relevant contracting parties and could never depend on laboratory selection, test volume, additional testing, or a particular scientific conclusion.

How a suitable evidence handoff begins

Non-Confidential Fit Check

Share the laboratory type, evidence area, recurring sponsor question, likely handoff model, region, and timing—without reports or client files.

Independence Review

Confirm conflicts, commercial separation, scientific boundaries, sponsor visibility, and any NDA or disclosure requirements.

Responsibility Map

Document who owns test design and reporting, evidence interpretation, sponsor communication, deliverables, fees, and review.

Authorised Evidence Handoff

Proceed only with authorised final materials and preserve the laboratory report, biological evaluation, decisions, and uncertainties as distinct records.

Non-Confidential Fit Check

Discuss an Evidence-to-Documentation Collaboration

Describe the laboratory, evidence area, intended sponsor handoff, geographic scope, and timing. Do not send protocols, reports, sponsor names, or device files at this stage.

A useful first note states

Your laboratory's general ISO 10993 capability area
The documentation question sponsors commonly bring
The preferred independent handoff model

Name *

Work Email *

Laboratory *

Your Role *

General Evidence Area *

Proposed Handoff *

Primary Markets / Regions

Laboratory Website

Non-Confidential Collaboration Need *

No laboratory reports, sponsor names, or device files at this stage.0 / 1400

Initial enquiry only. Do not include confidential reports, patient information, unpublished sponsor data, passwords, access links, or files. Safeguards can be agreed after fit and conflict review.

Submission is delivered to MedDev Advisory by FormSubmit and used to assess and respond to this collaboration enquiry, as described in the Privacy Policy.

Trust & Confidentiality